Novocure (NVCR) Misses Q4 EPS by 15c

Novocure (NASDAQ: NVCR) reported Q4 EPS of ($0.25), $0.15 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $133.2 million versus the consensus estimate of $135.42 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Micron Technology (MU) PT Raised to $1,550 at Needham
• Robinhood plans $2B convertible notes offering due 2029